August 1, 2011

The healthcare industry is in the midst of a revolutionary upheaval reflecting the concerns of patients, payers, providers, and policymakers over spiraling costs, lagging quality, and a lack of transparency. Healthcare providers are experimenting with a variety of approaches to address these issues, including offering “bundled prices” for episodes of care. This approach realigns provider incentives to deliver better care at lower cost, but it has a hidden side effect — commoditization.

In NAI’s article ECV: The Antidote to Commoditization Under Bundled Pricing, published by H&HN, August 2011, Managing Partner Michael N. Abrams, M.A., and Research Analyst Simone Cummings, Ph.D., describe why a strong economic and clinical value case is necessary, and how to build one.